These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 25448307

  • 21. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors.
    Thomas L, Eckhardt M, Langkopf E, Tadayyon M, Himmelsbach F, Mark M.
    J Pharmacol Exp Ther; 2008 Apr; 325(1):175-82. PubMed ID: 18223196
    [Abstract] [Full Text] [Related]

  • 22. Effects of DPP-4 inhibition on cardiac metabolism and function in mice.
    Lenski M, Kazakov A, Marx N, Böhm M, Laufs U.
    J Mol Cell Cardiol; 2011 Dec; 51(6):906-18. PubMed ID: 21871459
    [Abstract] [Full Text] [Related]

  • 23. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.
    Rajasekar P, Anuradha CV.
    Acta Diabetol; 2007 Jun; 44(2):83-90. PubMed ID: 17530472
    [Abstract] [Full Text] [Related]

  • 24. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW, Moore JE, Sharkey JA, Murphy G, Simpson DA, Bucala R, Vlassara H, Archer DB.
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [Abstract] [Full Text] [Related]

  • 25. Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization.
    Xie H, Zeng L, Zeng S, Lu X, Zhang G, Zhao X, Cheng N, Tu Z, Li Z, Xu H, Yang L, Zhang X, Huang M, Zhao J, Hu W.
    Eur J Med Chem; 2012 Jun; 52():205-12. PubMed ID: 22475866
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
    Rusinov VL, Sapozhnikova IM, Bliznik AM, Chupakhin ON, Charushin VN, Spasov AA, Vassiliev PM, Kuznetsova VA, Rashchenko AI, Babkov DA.
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28393419
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization.
    Zeng S, Xie H, Zeng LL, Lu X, Zhao X, Zhang GC, Tu ZC, Xu HJ, Yang L, Zhang XQ, Hu W.
    Bioorg Med Chem; 2013 Apr 01; 21(7):1749-55. PubMed ID: 23434133
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA, Khalifah RG, Hudson BG.
    Biochem Biophys Res Commun; 1996 Mar 07; 220(1):113-9. PubMed ID: 8602828
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Gemigliptin exerts protective effects against doxorubicin-induced hepatotoxicity by inhibiting apoptosis via the regulation of fibroblast growth factor 21 expression.
    Lee KM, Hwang YJ, Jung GS.
    Biochem Biophys Res Commun; 2022 Oct 20; 626():135-141. PubMed ID: 36049375
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of dipeptidyl peptidase activity by flavonol glycosides of guava (Psidium guajava L.): a key to the beneficial effects of guava in type II diabetes mellitus.
    Eidenberger T, Selg M, Krennhuber K.
    Fitoterapia; 2013 Sep 20; 89():74-9. PubMed ID: 23707747
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
    Kim MK, Chae YN, Kim HD, Yang EK, Cho EJ, Choi SH, Cheong YH, Kim HS, Kim HJ, Jo YW, Son MH, Kim SH, Shin CY.
    Life Sci; 2012 Jan 02; 90(1-2):21-9. PubMed ID: 22056373
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.